Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-02-21 @ 11:27 AM
Study NCT ID:
NCT02216669
Status:
WITHDRAWN
Last Update Posted:
2017-03-03
First Post:
2014-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer
Sponsor:
Maastricht Radiation Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2017-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-07
Completion Date Type:
ESTIMATED
First Submit Date:
2014-08-08
First Submit QC Date:
None
Study First Post Date:
2014-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-01
Last Update Post Date:
2017-03-03
Last Update Post Date Type:
ACTUAL